Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation.
A new agent for use in contrast echocardiography that is capable of passing through the pulmonary circulation and opacifying the left ventricular cavity after intravenous injection was evaluated in a canine model. Air-filled albumin microbubbles were produced by sonication. A Coulter counter was used to size and count the resultant microbubbles in vitro. The microbubbles had diameters sufficiently small (less than 9 micron) to permit transpulmonary passage. A total of 72 injections were made into the forepaw vein of five closed-chest dogs. Simultaneous two-dimensional echocardiographic images of the right ventricle and the left ventricle were recorded and digitized on an off-line computer. Of the 72 injections, 59 (82%) were suitable for digitization. Forty of the 59 digitized injections (68%) demonstrated left ventricular contrast enhancement. Indicator-dilution curves were generated from plots of intraventricular gray level VS time, and the curve widths and areas under the curves were determined. The ratio of total indicator curve area for left to right ventricular cavity was 0.39 for the 40 successful injections, indicating transpulmonary transmission of 39% of the contrast effect. Injection of bubbles with mean size less than 6 microns resulted in a larger median left ventricular curve area than those with bubbles averaging from 6 to 9 microns. Injections demonstrating successful left ventricular contrast opacification had larger right ventricular curve areas than those that were not successful. Blood pressure, heart rate, and arterial blood gases were not significantly altered by repeated intravascular contrast injections. Postmortem examination of hearts, lungs, livers, and kidneys revealed no histologic changes.(ABSTRACT TRUNCATED AT 250 WORDS)
Keller
M W
MW
Feinstein
S B
SB
Watson
D D
DD
D000818:Animals; D003287:Contrast Media; D004285:Dogs; D004452:Echocardiography / Q000379:methods*; D007201:Indicator Dilution Techniques; D007275:Injections, Intravenous; D009206:Myocardium / Q000473:pathology*; D012709:Serum Albumin; D013010:Sonication; D014463:Ultrasonography
D003287:Contrast Media; D012709:Serum Albumin